IN2012DN02642A - - Google Patents

Download PDF

Info

Publication number: IN2012DN02642A
Authority: IN; India
Prior art keywords: cells; oncogene; differentiation stage; present; desired differentiation
Prior art date: 2009-09-15

Application number

Other languages

English (en)

Inventor

Eto Koji

Takayama Naoya

Nakamura Sou

Nakauchi Hiromitsu

Original Assignee

Univ Tokyo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-09-15

Filing date

2010-09-15

Publication date

2015-09-11

2010-09-15 Application filed by Univ Tokyo filed Critical Univ Tokyo

2015-09-11 Publication of IN2012DN02642A publication Critical patent/IN2012DN02642A/en

Links

230000004069 differentiation Effects 0.000 abstract 4
238000004519 manufacturing process Methods 0.000 abstract 3
108700020796 Oncogene Proteins 0.000 abstract 2
230000026969 oncogene-induced senescence Effects 0.000 abstract 2
230000024245 cell differentiation Effects 0.000 abstract 1
230000001939 inductive effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0641—Erythrocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/18—Erythrocytes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0644—Platelets; Megakaryocytes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0634—Cells from the blood or the immune system
- C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/48—Regulators of apoptosis
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/60—Transcription factors
- C12N2501/606—Transcription factors c-Myc
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Biotechnology (AREA)
Hematology (AREA)
Genetics & Genomics (AREA)
Wood Science & Technology (AREA)
General Health & Medical Sciences (AREA)
Immunology (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Developmental Biology & Embryology (AREA)
Diabetes (AREA)
Virology (AREA)
Oncology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

IN2642DEN2012 2009-09-15 2010-09-15 IN2012DN02642A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2009213645		2009-09-15
PCT/JP2010/065903 WO2011034073A1 (fr)	2009-09-15	2010-09-15	Nouveau procédé de production de cellules différenciées

Publications (1)

Publication Number	Publication Date
IN2012DN02642A true IN2012DN02642A (fr)	2015-09-11

Family

ID=43758674

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IN2642DEN2012 IN2012DN02642A (fr)	2009-09-15	2010-09-15

Country Status (13)

Country	Link
US (2)	US9200254B2 (fr)
EP (2)	EP3159001B1 (fr)
JP (4)	JP5791191B2 (fr)
KR (2)	KR101667834B1 (fr)
CN (2)	CN105385659B (fr)
AU (1)	AU2010296415B2 (fr)
BR (2)	BR122013008030B8 (fr)
CA (1)	CA2774193C (fr)
DK (2)	DK3159001T3 (fr)
ES (2)	ES2664194T3 (fr)
IN (1)	IN2012DN02642A (fr)
RU (2)	RU2603094C2 (fr)
WO (1)	WO2011034073A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2012043651A1 (fr) *	2010-09-30	2012-04-05	国立大学法人熊本大学	Procédé de production de globules sanguins myéloïdes
EP2708597B1 (fr) *	2011-05-13	2017-11-15	The University of Tokyo	Cellule mégakariocytaire polynuclée et procédé de production de plaquettes
RU2014117642A (ru) *	2011-10-03	2015-11-10	Ниссан Кемикал Индастриз, Лтд.	Способ получения мегакариоцитов и/или тромбоцитов из плюрипотентных стволовых клеток
GB201210857D0 (en)	2012-06-19	2012-08-01	Cambridge Entpr Ltd	Transcription factor mediated programming towards megakaryocytes
CA2896053A1 (fr)	2012-12-21	2014-06-26	Ocata Therapeutics, Inc.	Procedes de production de plaquettes a partir de cellules souches pluripotentes, et compositions associees
EP2955223B1 (fr)	2013-02-08	2019-12-18	Kyoto University	Procédés de production de mégacaryocytes et de plaquettes
WO2014168255A1 (fr) *	2013-04-12	2014-10-16	国立大学法人京都大学	Accélérateur de la maturation de mégacaryocytes
WO2014171486A1 (fr)	2013-04-17	2014-10-23	日産化学工業株式会社	Composition de milieu et procédé de production de globules rouges l'utilisant
CN111876387A (zh) *	2013-05-15	2020-11-03	罗切斯特大学	人广泛自我更新型成红细胞(esre)
US10112977B2 (en)	2014-06-23	2018-10-30	Toagosei Co., Ltd.	Peptide for inducing multinucleation in cells, and use therefor
AU2016230059A1 (en)	2015-03-09	2017-09-28	Kyoto University	Method for producing culture containing megakaryocytes, and method for producing platelets using same
RU2730034C2 (ru) *	2015-04-14	2020-08-14	Киото Юниверсити	Способ получения клона стволовых клеток, пригодного для индуцирования дифференцировки в соматические клетки
KR20160129609A (ko)	2015-04-30	2016-11-09	삼성전자주식회사	Ｂｒａｆ 저해제를 포함하는 세포 또는 개체의 노화를 감소시키기 위한 조성물 및 그의 용도
ES2833357T3 (es) *	2015-11-02	2021-06-15	Megakaryon Corp	Procedimiento de preparación de plaquetas con un dispositivo de agitación recíproca
ES3016741T3 (en)	2016-01-29	2025-05-09	Univ Kyoto	Screening method of platelet production promoter
EP3453759B1 (fr)	2016-01-29	2023-08-30	Kyoto University	Promoteur de production plaquettaire et procédé de production plaquettaire au moyen de celui-ci
WO2018164040A1 (fr)	2017-03-06	2018-09-13	国立大学法人京都大学	Procédé de production de plaquettes
FR3068366B1 (fr) *	2017-06-30	2023-11-24	Francais Du Sang Ets	Procede de production de progeniteurs erythroides
JP7153276B2 (ja)	2017-07-07	2022-10-14	国立大学法人京都大学	血小板の製造方法および製造装置、ならびに血小板の製造装置における運転条件の決定方法
WO2019059235A1 (fr)	2017-09-19	2019-03-28	株式会社メガカリオン	Procédé de fabrication de plaquettes sanguines purifiées, procédé de fabrication de préparation de plaquettes sanguines, procédé de fabrication de préparation sanguine, fluide de conservation de plaquettes sanguines, agent de conservation de plaquettes sanguines et procédé de conservation de plaquettes sanguines
US12091683B2 (en)	2017-09-19	2024-09-17	Megakaryon Corporation	Method for producing platelets, method for producing platelet product, and method for producing blood product
EP3700334B1 (fr)	2017-10-27	2026-04-08	Immunebridge Inc.	Compositions et procédés de production de cellules souches hématopoïétiques expansées mettant en oeuvre des dérivés de fluorène
CA3087344A1 (fr)	2018-01-05	2019-07-11	Platelet Biogenesis, Inc.	Compositions et procedes pour produire des megacaryocytes
JP2021529770A (ja)	2018-06-29	2021-11-04	プレートレットバイオジェネシス，インコーポレイテッド	薬物送達のための組成物およびその使用方法
TW202045202A (zh) *	2019-02-25	2020-12-16	國立陽明大學	用於治療肺纖維化和肺氣腫的組合物及其使用方法
WO2020223517A1 (fr) *	2019-05-01	2020-11-05	Transfusion Health, Llc	Procédés de fabrication de précurseurs oligopotents et unipotents
JP7058431B2 (ja) *	2019-12-12	2022-04-22	国立大学法人千葉大学	巨核球および血小板を含む凍結乾燥製剤
US20230046238A1 (en)	2019-12-13	2023-02-16	Megakaryon Corporation	Composition and use thereof
CN116437940A (zh)	2020-10-27	2023-07-14	国立大学法人长崎大学	骨形成组合物和其用途
JP7716851B2 (ja) *	2020-12-28	2025-08-01	イビデン株式会社	凍結保存液
KR20240019327A (ko)	2021-06-18	2024-02-14	가부시키가이샤 메가카리온	혈소판 산생능이 증강된 다핵화 거핵구 세포의 제조 방법, 혈소판의 제조 방법, 혈소판 제제의 제조 방법 및 혈액 제제의 제조 방법
EP4365283A4 (fr)	2021-06-30	2025-06-11	National University Corporation Chiba University	Procédé d'amélioration des propriétés prolifératives de cellules myéloïdes progénitrices communes (cmp) ou de cellules progénitrices myélocytiques
WO2024010317A1 (fr) *	2022-07-04	2024-01-11	주식회사 아트블러드	Établissement d'une lignée cellulaire progénitrice érythroïde immortalisée ayant une capacité supérieure de différenciation en globules rouges par l'utilisation d'une combinaison de surexpression génétique, son procédé de préparation et son utilisation
WO2024085650A1 (fr)	2022-10-18	2024-04-25	의료법인 성광의료재단	Composition de milieu pour induire la différenciation d'une cellule souche en cellule progénitrice plaquettaire et procédé de différenciation l'utilisant
CN120641558A (zh)	2022-12-28	2025-09-12	国立大学法人千叶大学	细胞分化度的调节方法
CN121219404A (zh)	2023-04-03	2025-12-26	大塚制药株式会社	巨核细胞的制造方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US572333A (en)		1896-12-01		Evaporating apparatus
EP0591420A1 (fr)	1991-06-28	1994-04-13	New England Deaconess Hospital	Lignee de megacaryocytes differencies produisant de nouveaux facteurs de differenciation de megacaryocytes
GB9502022D0 (en) *	1995-02-02	1995-03-22	Abuljadayel Ilham M S	A method for preparing lymphohaematopoietic progenitor cells
US5723333A (en)	1995-02-10	1998-03-03	Regents Of The University Of California	Human pancreatic cell lines: developments and uses
DE69635513T2 (de)	1995-02-10	2006-08-17	The Regents Of The University Of California, Oakland	Menschliche Pancreas Zelllinien: Entwicklungen und Anwendungen
US20050159378A1 (en) *	2001-05-18	2005-07-21	Sirna Therapeutics, Inc.	RNA interference mediated inhibition of Myc and/or Myb gene expression using short interfering nucleic acid (siNA)
WO2004029208A2 (fr) *	2002-09-27	2004-04-08	Bioe, Inc.	Compositions et procedes de separation de cellules
JP3896482B2 (ja) *	2002-10-07	2007-03-22	独立行政法人産業技術総合研究所	分化細胞の作製方法
JP2004350601A (ja)	2003-05-29	2004-12-16	Tanabe Seiyaku Co Ltd	霊長類動物の胚性幹細胞から造血系細胞への分化方法
JP4706208B2 (ja)	2004-08-27	2011-06-22	株式会社アイル	造血幹細胞の製造方法
JP2006141356A (ja)	2004-11-24	2006-06-08	Institute Of Physical & Chemical Research	Ｅｓ細胞から樹立された造血幹細胞
US8883507B2 (en)	2005-10-18	2014-11-11	The Regents Of The University Of Colorado	Conditionally immortalized long-term hematopoietic stem cells and methods of making and using such cells
WO2007056423A1 (fr) *	2005-11-07	2007-05-18	The General Hospital Corporation	Procedes et compositions de modulation du vieillissement des cellules souches
EP2206724A1 (fr) *	2005-12-13	2010-07-14	Kyoto University	Facteur de reprogrammation nucléaire
US8058064B2 (en)	2006-10-04	2011-11-15	The University Of Tokyo	Sac-like structure enclosing hematopoietic progenitor cells produced from ES cells and method for preparing blood cells
AU2008297024B2 (en) *	2007-10-31	2014-08-28	Kyoto University	Nuclear reprogramming method
CN101492676B (zh) *	2008-09-16	2011-02-16	中国科学院广州生物医药与健康研究院	用脑膜细胞生成诱导的多能性干细胞的方法及其用途

2010
- 2010-09-15 BR BR122013008030A patent/BR122013008030B8/pt active IP Right Grant
- 2010-09-15 CA CA2774193A patent/CA2774193C/fr active Active
- 2010-09-15 BR BR112012005710A patent/BR112012005710B1/pt active IP Right Grant
- 2010-09-15 RU RU2012114427/10A patent/RU2603094C2/ru active
- 2010-09-15 DK DK16202612.4T patent/DK3159001T3/da active
- 2010-09-15 DK DK10817186.9T patent/DK2500418T3/en active
- 2010-09-15 IN IN2642DEN2012 patent/IN2012DN02642A/en unknown
- 2010-09-15 EP EP16202612.4A patent/EP3159001B1/fr active Active
- 2010-09-15 CN CN201510530896.9A patent/CN105385659B/zh not_active Expired - Fee Related
- 2010-09-15 KR KR1020127009225A patent/KR101667834B1/ko active Active
- 2010-09-15 AU AU2010296415A patent/AU2010296415B2/en active Active
- 2010-09-15 JP JP2011531940A patent/JP5791191B2/ja active Active
- 2010-09-15 ES ES10817186.9T patent/ES2664194T3/es active Active
- 2010-09-15 ES ES16202612T patent/ES2725688T3/es active Active
- 2010-09-15 EP EP10817186.9A patent/EP2500418B1/fr active Active
- 2010-09-15 RU RU2016139042A patent/RU2661107C1/ru active
- 2010-09-15 CN CN201080042161.7A patent/CN102712906B/zh active Active
- 2010-09-15 WO PCT/JP2010/065903 patent/WO2011034073A1/fr not_active Ceased
- 2010-09-15 US US13/496,321 patent/US9200254B2/en active Active
- 2010-09-15 KR KR1020167027550A patent/KR101834687B1/ko active Active
2015
- 2015-02-13 JP JP2015026547A patent/JP2015130866A/ja active Pending
- 2015-08-03 JP JP2015153048A patent/JP6265437B2/ja active Active
- 2015-10-28 US US14/925,508 patent/US10087419B2/en active Active
2016
- 2016-11-29 JP JP2016231020A patent/JP6382917B2/ja active Active

Also Published As

Publication number	Publication date
CN102712906A (zh)	2012-10-03
KR101834687B1 (ko)	2018-03-05
JP6265437B2 (ja)	2018-01-24
EP2500418B1 (fr)	2018-01-17
RU2012114427A (ru)	2013-10-27
CN105385659B (zh)	2019-06-28
KR20120064109A (ko)	2012-06-18
KR20160121592A (ko)	2016-10-19
CA2774193C (fr)	2020-08-25
EP3159001A1 (fr)	2017-04-26
JP2015130866A (ja)	2015-07-23
DK3159001T3 (da)	2019-06-17
US9200254B2 (en)	2015-12-01
DK2500418T3 (en)	2018-04-30
WO2011034073A1 (fr)	2011-03-24
JP2017046719A (ja)	2017-03-09
RU2661107C1 (ru)	2018-07-11
US20160115449A1 (en)	2016-04-28
JPWO2011034073A1 (ja)	2013-02-14
BR122013008030A2 (pt)	2019-08-06
AU2010296415A1 (en)	2012-04-05
EP2500418A1 (fr)	2012-09-19
BR112012005710B1 (pt)	2020-06-09
KR101667834B1 (ko)	2016-10-20
US20120238023A1 (en)	2012-09-20
AU2010296415B2 (en)	2014-07-03
CA2774193A1 (fr)	2011-03-24
EP3159001B1 (fr)	2019-03-06
BR122013008030B8 (pt)	2021-07-27
JP5791191B2 (ja)	2015-10-07
BR122013008030B1 (pt)	2021-01-05
CN102712906B (zh)	2015-09-30
RU2603094C2 (ru)	2016-11-20
CN105385659A (zh)	2016-03-09
US10087419B2 (en)	2018-10-02
JP6382917B2 (ja)	2018-08-29
JP2015213520A (ja)	2015-12-03
BR112012005710A2 (pt)	2017-11-21
EP2500418A4 (fr)	2013-04-10
ES2664194T3 (es)	2018-04-18
ES2725688T3 (es)	2019-09-26

Publication	Publication Date	Title
PH12013500554A1 (en)	2013-05-06	Process for preparing pan-cdk inhibitors of the formula (i) and intermediates in the preparation
TN2011000673A1 (en)	2013-05-24	Bace inhibitors
BR122013008030B8 (pt)	2021-07-27	método para produzir células eritroides e método para produzir um produto sanguíneo
PH12013500760B1 (en)	2019-05-22	Microorganism producing o-phosphoserine and method of producing l-cysteine or derivatives thereof from o-phosphoserine using the same
MY163339A (en)	2017-09-15	A method of producing ingenol-3-angelate
EP2671964A4 (fr)	2017-06-14	Feuille d'acier laminée à froid à haute résistance, ayant une excellente aptitude au traitement et un rapport d'élasticité élevé, et son procédé de fabrication
EA201270280A1 (ru)	2013-01-30	Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
IN2012KN02804A (fr)	2015-05-01
MX369049B (es)	2019-10-28	Aparato para producir aceros recocidos y proceso para producir dichos aceros.
MX2011008621A (es)	2011-09-15	Proceso para la purificacion de lipopeptidos.
IN2012DN01342A (fr)	2015-06-05
MX2012007341A (es)	2012-07-20	Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
TN2013000385A1 (en)	2015-01-20	Processes for the manufacture of macrocyclic depsipeptides and new intermediates
IN2015DN01812A (fr)	2015-05-29
MX2011013790A (es)	2012-03-14	Derivados de flavina.
UA106988C2 (uk)	2014-11-10	Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та необхідні проміжні сполуки магнію
PH12012501153A1 (en)	2012-10-22	Process for synthesis of intermediates useful for making substituted indazole and azaindazole compounds
MX339772B (es)	2016-06-09	Metodo y composicion para producir azucar clarificada.
IN2012DN01929A (fr)	2015-07-24
MX2012010443A (es)	2012-12-05	Proceso para la preparacion de 1-alquiltetrazoles 5-sustituidos.
WO2010059916A3 (fr)	2010-07-15	Préparation de docétaxel
IN2012DN03032A (fr)	2015-07-31
WO2013072766A3 (fr)	2013-08-15	Procédé de fabrication de cabazitaxel et de ses intermédiaires
MX2011012460A (es)	2012-04-20	Proceso para la preparacion de olmesartan medoxomil.
WO2010029457A3 (fr)	2010-12-29	Procédé de préparation amélioré du losartan potassique